Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
RESEARCH TOOLSreports
Kymera Therapeutics (KYMR) Ownership Overview
28.27% Insiders
30.51% Mutual Funds
0.06% Other Institutional Investors
13.12% ETFs
28.02% Public Companies and Individual Investors
The ownership structure of Kymera Therapeutics (KYMR) stock is a mix of institutional, retail, and individual investors. Approximately 43.70% of the company’s stock is owned by Institutional Investors, 28.27% is owned by Insiders, and 28.02% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 22, 2024 | Baker Bros. Advisors Lp Director | xxxxxxxxxxxxx | $46 |
| May 23, 2024 | xxxxxxxxxxxxx | $90099 | |
| Mar 04, 2024 | xxxxxxxxxxxxx | $164651 | |
| Mar 04, 2024 | Jared Gollob Cmo | xxxxxxxxxxxxx | $139956 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $4842605 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $13129020 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $21620728 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $23856390 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,995,929 | Institution | 9.26% | 221,129,862 | |
| 5,995,929 | Insider | 9.26% | 221,129,862 | |
| 5,504,905 | Insider | 8.50% | 203,020,896 | |
| 5,054,898 | Insider | 7.80% | 186,424,638 | |
| 4,639,029 | Institution | 7.16% | 171,087,390 | |
| 4,091,542 | Institution | 6.32% | 150,896,069 | |
| 3,140,871 | Institution | 4.85% | 115,835,322 | |
| 2,547,968 | Institution | 3.93% | 93,969,060 | |
| 2,253,808 | Institution | 3.48% | 83,120,439 | |
| 2,116,943 | Institution | 3.27% | 78,072,858 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,091,542 | Institution | 6.32% | 150,896,069 | |
| 3,140,871 | Institution | 4.85% | 115,835,322 | |
| 2,547,968 | Institution | 3.93% | 93,969,060 | |
| 2,116,943 | Institution | 3.27% | 78,072,858 | |
| 1,196,306 | Institution | 1.85% | 44,119,765 | |
| 967,593 | Institution | 1.49% | 35,684,830 | |
| 604,669 | Institution | 0.93% | 22,300,193 | |
| 507,902 | Institution | 0.78% | 18,731,426 | |
| 487,336 | Institution | 0.75% | 17,972,952 | |
| 455,765 | Institution | 0.70% | 16,808,613 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,529,624 | Institution | 2.36% | 61,536,774 | |
| 1,264,883 | Institution | 1.95% | 46,648,885 | |
| 1,236,991 | Institution | 1.91% | 49,764,148 | |
| 719,775 | Institution | 1.11% | 28,956,548 | |
| 699,006 | Institution | 1.08% | 28,121,011 | |
| 608,992 | Institution | 0.94% | 22,307,377 | |
| 418,588 | Institution | 0.65% | 15,437,525 | |
| 343,259 | Institution | 0.53% | 12,659,392 | |
| 223,564 | Institution | 0.35% | 8,189,149 | |
| 222,463 | Institution | 0.34% | 8,949,686 |
FAQ
Who Owns Kymera Therapeutics (KYMR)?
According to the latest TipRanks data, approximately 0.06% of the company's stock is held by institutional investors, 28.27% is held by insiders, and 28.02% is held by retail investors.
What percentage of Kymera Therapeutics (KYMR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.06% of Kymera Therapeutics (KYMR) stock is held by institutional investors.
What percentage of Kymera Therapeutics (KYMR) stock is held by retail investors?
According to the latest TipRanks data, approximately 28.02% of Kymera Therapeutics (KYMR) stock is held by retail investors.
Who owns the most shares of Kymera Therapeutics (KYMR)?
Felix Baker owns the most shares of Kymera Therapeutics (KYMR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.